Chrome Extension
WeChat Mini Program
Use on ChatGLM
VIPCreated with Sketch.

Targeting Molecular Measurable Residual Disease and Low-Blast Relapse in AML with Venetoclax and Low-Dose Cytarabine: A Prospective Phase II Study (VALDAC).

Ing Soo Tiong,Devendra K. Hiwase,Emad Abro,Ashish Bajel,Emma Palfreyman,Ashanka Beligaswatte,John Reynolds,Natasha Anstee,Tamia Nguyen,Sun Loo,Chong Chyn Chua, Michael Ashby, Kaitlyn M. Wiltshire,Shaun Fleming,Chun Y. Fong,Tse-Chieh Teh,Piers Blombery,Richard Dillon,Adam Ivey,Andrew H. Wei

JOURNAL OF CLINICAL ONCOLOGY（2024）

Cited 4|Views36
Key words
Relapse Risk,Minimal Residual Disease,Treatment Outcomes
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined